首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 2-((3R,12S,24R,29R,32S,38S,41S,47R,50S,56S,59R,64R,67S,73S,79S,84aS)-64-氨基-9,32,67,73-四(4-氨基丁基)-29-氨基甲酰基-6,38,41-三(3-胍基丙基)-18-(4-羟基苄基)-12-((R)-1-羟基乙基)-50,56-双(羟甲基)-79-甲基-15-(2-(甲硫基)乙基)-1,4,7,10,13,16,19,22,31,34,37,40,43,46,49,52,55,58,65,68,71,74,77,80,86-二十五氧杂八十七氢-1H,28H-59,24-(亚氨基甲撑)-3,47-(甲撑二硫代甲撑)吡咯并[2,1-b1][1,2,48,49]四硫杂[5,8,11,14,17,20,23,26,29,32,35,38,41,44,53,56,59,62,65,68,71,74,77,80]二十四氮杂环二十八烯-21-基)乙酸

2-((3R,12S,24R,29R,32S,38S,41S,47R,50S,56S,59R,64R,67S,73S,79S,84aS)-64-氨基-9,32,67,73-四(4-氨基丁基)-29-氨基甲酰基-6,38,41-三(3-胍基丙基)-18-(4-羟基苄基)-12-((R)-1-羟基乙基)-50,56-双(羟甲基)-79-甲基-15-(2-(甲硫基)乙基)-1,4,7,10,13,16,19,22,31,34,37,40,43,46,49,52,55,58,65,68,71,74,77,80,86-二十五氧杂八十七氢-1H,28H-59,24-(亚氨基甲撑)-3,47-(甲撑二硫代甲撑)吡咯并[2,1-b1][1,2,48,49]四硫杂[5,8,11,14,17,20,23,26,29,32,35,38,41,44,53,56,59,62,65,68,71,74,77,80]二十四氮杂环二十八烯-21-基)乙酸

2-((3R,12S,24R,29R,32S,38S,41S,47R,50S,56S,59R,64R,67S,73S,79S,84aS)-64-amino-9,32,67,73-tetrakis(4-aminobutyl)-29-carbamoyl-6,38,41-tris(3-guanidinopropyl)-18-(4-hydroxybenzyl)-12-((R)-1-hydroxyethyl)-50,56-bis(hydroxymethyl)-79-methyl-15-(2-(methylthio)ethyl)-1,4,7,10,13,16,19,22,31,34,37,40,43,46,49,52,55,58,65,68,71,74,77,80,86-pentacosaoxooctaheptacontahydro-1H,28H-59,24-(epiminomethano)-3,47-(methanodithiomethano)pyrrolo[2,1-b1][1,2,48,49]tetrathia[5,8,11,14,17,20,23,26,29,32,35,38,41,44,53,56,59,62,65,68,71,74,77,80]tetracosaazacyclodooctacontin-21-yl)acetic acid

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

147794-23-8

中文名称

2-((3R,12S,24R,29R,32S,38S,41S,47R,50S,56S,59R,64R,67S,73S,79S,84aS)-64-氨基-9,32,67,73-四(4-氨基丁基)-29-氨基甲酰基-6,38,41-三(3-胍基丙基)-18-(4-羟基苄基)-12-((R)-1-羟基乙基)-50,56-双(羟甲基)-79-甲基-15-(2-(甲硫基)乙基)-1,4,7,10,13,16,19,22,31,34,37,40,43,46,49,52,55,58,65,68,71,74,77,80,86-二十五氧杂八十七氢-1H,28H-59,24-(亚氨基甲撑)-3,47-(甲撑二硫代甲撑)吡咯并[2,1-b1][1,2,48,49]四硫杂[5,8,11,14,17,20,23,26,29,32,35,38,41,44,53,56,59,62,65,68,71,74,77,80]二十四氮杂环二十八烯-21-基)乙酸

英文名称

2-((3R,12S,24R,29R,32S,38S,41S,47R,50S,56S,59R,64R,67S,73S,79S,84aS)-64-amino-9,32,67,73-tetrakis(4-aminobutyl)-29-carbamoyl-6,38,41-tris(3-guanidinopropyl)-18-(4-hydroxybenzyl)-12-((R)-1-hydroxyethyl)-50,56-bis(hydroxymethyl)-79-methyl-15-(2-(methylthio)ethyl)-1,4,7,10,13,16,19,22,31,34,37,40,43,46,49,52,55,58,65,68,71,74,77,80,86-pentacosaoxooctaheptacontahydro-1H,28H-59,24-(epiminomethano)-3,47-(methanodithiomethano)pyrrolo[2,1-b1][1,2,48,49]tetrathia[5,8,11,14,17,20,23,26,29,32,35,38,41,44,53,56,59,62,65,68,71,74,77,80]tetracosaazacyclodooctacontin-21-yl)acetic acid

别名

CYS-LYS-GLY-LYS-GLY-ALA-PRO-CYS-ARG-LYS-THR-MET-TYR-ASP-CYS-CYS-SER-GLY-SER-CYS-GLY-ARG-ARG-GLY-LYS-CYS-NH2;CKGKGAPCRKTMYDCCSGSCGRRGKC-NH2 (DISULFIDE BRIDGE: 1-16,8-20 AND 15-26);w-Conotoxin MVIIC, Conus magus;w-ConotoxinMVIIC;ω-conotoxin mviic;M.W. 2749.70 C106H178N40O32S7;Omega-conotoxin m viia (reduced), 7-L-proline-9-L-arginine-10-L-lysine-11-L-threonine-17-L-serine-20A-endo-glycine-22-L-arginine-, cycli (1-16),(8-20),(15-25)-tris(disulfide);Omega-ctx-mviic

标准英文名

2-((3R,12S,24R,29R,32S,38S,41S,47R,50S,56S,59R,64R,67S,73S,79S,84aS)-64-amino-9,32,67,73-tetrakis(4-aminobutyl)-29-carbamoyl-6,38,41-tris(3-guanidinopropyl)-18-(4-hydroxybenzyl)-12-((R)-1-hydroxyethyl)-50,56-bis(hydroxymethyl)-79-methyl-15-(2-(methylthio)ethyl)-1,4,7,10,13,16,19,22,31,34,37,40,43,46,49,52,55,58,65,68,71,74,77,80,86-pentacosaoxooctaheptacontahydro-1H,28H-59,24-(epiminomethano)-3,47-(methanodithiomethano)pyrrolo[2,1-b1][1,2,48,49]tetrathia[5,8,11,14,17,20,23,26,29,32,35,38,41,44,53,56,59,62,65,68,71,74,77,80]tetracosaazacyclodooctacontin-21-yl)acetic acid

MDL No.

MFCD00214640

分子式

C106H178N40O32S7

分子量

2749.31

精确分子量

2747.16

SMILES

CSCC[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CSSC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N4CCC[C@H]4C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC3=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O

标准SMILES

CSCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CSSC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N4CCC[C@H]4C(=O)N2)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC3=O)C(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC2C=CC(O)=CC=2)NC1=O)[C@@H](C)O

用途

ω-Conotoxin MVIIC is a blocker of N- and P/Q-type voltage-gated calcium channels (Ca²⁺ channels) and significantly antagonizes the inhibition of glutamate release mediated by 11-keto-β-boswellic acid; it exhibits potential as a pharmaceutical lead compound due to its stable structure, high specificity for calcium channel subtypes in the mammalian central nervous system, and minimal impact on bioactivity despite multiple lysine residues.

InChIKey

FHVUTHWUIUXZBY-QLANQDRJSA-N

安全信息

SureRoute逆合成路线

1.  147794-23-8 逆合成路线 1

—
—
ACCWUB499
147794-23-8
来源: SureRoute

2.  147794-23-8 逆合成路线 2

—
—
ACCWUB499
147794-23-8
来源: SureRoute

3.  147794-23-8 逆合成路线 3

—
—
ACCWUB499
147794-23-8
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手